跳至主要内容
临床试验/DRKS00015171
DRKS00015171招募中未知

ovel surgical treatment approaches based on ontogenetic anatomy for vaginal and cervical cancer: TMMR, KMMR, EMMR, LEER and tLNE

niversitätsklinikum Leipzig0 个研究点目标入组 600 人开始时间: 2018年10月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Patients with histologically proven cervical carcinoma FIGO stages I B to II B or Müllerian vaginal carcinoma FIGO stage I or II without clinical evidence of involvement of the urethrovesical wall.
  • OR: Patients with histologically proven cervical carcinoma FIGO stages IIB / vaginal carcinoma FIGO stage II suspect for urethrovesical wall involvement or cervical carcinoma FIGO stages IIIA, B, IVA / Müllerian vaginal carcinoma FIGO stages III, IVA. In theses cases, the patients must insist on surgical treatment even after consultation with an radio-oncologist for information about the standard therapy.

排除标准

  • Compromised general condition (Karnowsky index < 80%) or other comorbidity rendering the necessary surgery an inacceptable risk. Physical or psychological inability to cope with the expected sequelae of the operation. Previous pelvic radiation.
  • Previous major pelvic surgery (excluding simple hysterectomy). Advanced tumors infiltrating derivatives of external somatic coelom. Neuroendocrine tumors.

研究者

发起方
niversitätsklinikum Leipzig

相似试验